FTO and nonpapillary renal cell carcinoma: After four weeks, downregulation of FTO significantly impairs ccRCC lung metastasis (Fig. 5c) and the number of lung metastatic lesions (Fig. 5d) compared with those in control groups, and this inhibitory was partially relieved by 3-MA treatment.